Market Wrap | US Stocks Surge on Fed Speculation and Sector Gains

On June 10, 2025, the U.S. stock market saw gains across major indices, with the S&P 500 rising 0.55%, the Dow Jones Industrial Average up 0.25%, and the Nasdaq Composite increasing 0.63%. The market's positive sentiment was bolstered by macroeconomic news, including speculation that the U.S. Treasury Secretary could be a strong contender for the next Federal Reserve Chair, despite White House denials. Additionally, the probability of the Federal Reserve maintaining interest rates in June is 99.9%, with a slight chance of a rate change in July.

In today's market, several sectors outperformed the S&P 500, including technology, healthcare, discretionary consumer goods, energy, communication services, materials, and real estate. Notably, the healthcare, discretionary consumer goods, energy, and communication services sectors demonstrated exceptional performance. Conversely, the industrial sector moved in the opposite direction of the S&P 500.

Eli Lilly shares rose 4.33%, with analysts forecasting an average target price of $967.71, suggesting potential upside. Novo Nordisk saw a 5.13% increase, driven by strong sales and earnings per share growth in Q1, fueled by surging demand for GLP-1. Tesla's stock rose 5.67%, following a 3.40% gain after being named the official operator of autonomous vehicles in Austin.

CARISMA Therapeutics surged over 389% as three analysts revised their earnings estimates upwards in the last 60 days. Evogene rose 100% following the successful launch of an advanced AI model with Google Cloud, enhancing its capabilities in pharmaceutical and agriculture sectors. Baiya International dropped over 50% as the waiver of IPO lock-up allowed the sale of 2,950,000 shares, potentially diluting stock value. Unicycive fell over 40% after the FDA identified compliance deficiencies at a third-party manufacturing vendor, halting NDA label discussions for Unicycive's drug.

请提供新闻内容以便进行筛选和总结。